To develop and not to do much harm

How to carry out import substitution of the medical products, the operating shareholder JOINT-STOCK COMPANY "ANGIOLAYN CHINA DISTRIBUTION" Even in case of the termination of deliveries of medical products from Europe, America and Japan the majority of similar products can find analogs to India and China. It is possible to adjust new channels of import due to introduction of the simplified system of registration of foreign medical products, but it has to be very selective and cover the list of that production on which really there is a deficiency and complexity of start of productions to Russian Federation. It is important to promote start of productions to Russian Federation. The main problem at import substitution...